| Code | CSB-AP000371HU |
| Abbreviation | Recombinant Human SHH protein, partial (Active) |
| MSDS | |
| Size | $142 |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
Sonic hedgehog signaling drives critical patterning events in development and is frequently dysregulated in cancers such as basal cell carcinoma and medulloblastoma, making precise pathway reconstitution essential for tumor biology research. This tag-free recombinant human SHH fragment (residues 25–197) encompasses the biologically active N-terminal signaling domain and demonstrates an ED50 below 1 μg/ml in a C3H/10T1/2 alkaline phosphatase induction assay, corresponding to a specific activity exceeding 1.0 × 10³ IU/mg—performance that supports osteogenic differentiation studies, stem cell fate commitment experiments, and receptor-ligand binding assays using SPR or ELISA formats. The E. coli expression system yields a non-glycosylated protein that provides a defined baseline for dissecting glycosylation-independent Patched-1 binding interactions. Purity exceeding 98% by SDS-PAGE combined with endotoxin levels below 1.0 EU/μg satisfies the criteria typical for cell-based proliferation assays and in vivo tumor biology models requiring minimal innate immune interference.
There are currently no reviews for this product.